Swansea University and the Methodist Hospital
Research Institute offers Fully-Funded PhD Studentship in Development
of Point of Care Diagnostics for Heart Disease Biomarkers. The studentship
is only available to candidates from the UK/EU. Students should have
an interest in micro-fabrication and application of semiconductor processing
technology in medical products. The first year of the PhD will be
completed at Swansea University. In years 2 and 3, the student will continue
their PhD as an employee of The Methodist Hospital Research Institute, Texas
and be based in Texas. For the final 12 months of the PhD, the student will return
to Swansea University to complete the PhD. The application deadline
is May 31st 2013.
Study Subject(s): This studentship is provided in the field of engineering.
Course Level: This studentship is available for pursuing
PhD degree level at Swansea University.
Scholarship Provider: Swansea University and the Methodist Hospital
Research Institute, UK
Scholarship can be taken at: The first year of the PhD will be
completed at Swansea University, UK. In years 2 and 3, the student will
continue their PhD as an employee of The Methodist Hospital Research Institute,
Texas, USA.
Course Level: This studentship is available for pursuing
PhD degree level at Swansea University.
Scholarship Provider: Swansea University and the Methodist Hospital
Research Institute, UK
Scholarship can be taken at: The first year of the PhD will be
completed at Swansea University, UK. In years 2 and 3, the student will
continue their PhD as an employee of The Methodist Hospital Research Institute,
Texas, USA.
Eligibility: The studentship is only available to candidates from the
UK/EU. Students should have an interest in micro-fabrication and
application of semiconductor processing technology in medical products.
UK/EU. Students should have an interest in micro-fabrication and
application of semiconductor processing technology in medical products.
Scholarship Open for International Students: The students of Austria, Belgium, Bulgaria, Cyprus, Czech Republic,
Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy,
Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania,
Slovakia, Slovenia, Spain, Sweden and UK can apply for this studentship.
Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy,
Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania,
Slovakia, Slovenia, Spain, Sweden and UK can apply for this studentship.
Scholarship Description: This is a joint project between Swansea University and The
Methodist Hospital Research Institute, Texas. The first year of the PhD
will be completed at Swansea University. In years 2 and 3, the student will
continue their PhD as an employee of The Methodist Hospital Research Institute,
Texas and be based in Texas. For the final 12 months of the PhD, the student
will return to Swansea University to complete the PhD. The World Health
Organisation (WHO) figures from 2008 determined that ischemic heart disease
followed by stroke is responsible for 23.6% of all global mortalities. The
diagnosis and management of acute ischemic stroke is limited by the lack of
rapid diagnostic assays for use in both an emergency and community-based
setting. The ability to correlate blood-based protein biomarkers with stroke
would aid in the development of such rapid diagnostics. This proposed programme
of research would focus on the development of a point of care (POC) diagnostic
system based on a silicon nanowire biosensor chip integrated with a micofluidic
flow cell.
Methodist Hospital Research Institute, Texas. The first year of the PhD
will be completed at Swansea University. In years 2 and 3, the student will
continue their PhD as an employee of The Methodist Hospital Research Institute,
Texas and be based in Texas. For the final 12 months of the PhD, the student
will return to Swansea University to complete the PhD. The World Health
Organisation (WHO) figures from 2008 determined that ischemic heart disease
followed by stroke is responsible for 23.6% of all global mortalities. The
diagnosis and management of acute ischemic stroke is limited by the lack of
rapid diagnostic assays for use in both an emergency and community-based
setting. The ability to correlate blood-based protein biomarkers with stroke
would aid in the development of such rapid diagnostics. This proposed programme
of research would focus on the development of a point of care (POC) diagnostic
system based on a silicon nanowire biosensor chip integrated with a micofluidic
flow cell.
What does it cover? The joint studentship is fully funded by Swansea University and the
Methodist Hospital Research Institute. The studentship covers:
-Full UK/EU tuition fees.
-Annual tax-free bursary beginning at £13,726 (payable monthly) in the first
year.
-a salary of $30,000 per annum in years 2 and 3.
-and a 6 month bursary in year 4.
-Funds will be available to support travel where appropriate.
Methodist Hospital Research Institute. The studentship covers:
-Full UK/EU tuition fees.
-Annual tax-free bursary beginning at £13,726 (payable monthly) in the first
year.
-a salary of $30,000 per annum in years 2 and 3.
-and a 6 month bursary in year 4.
-Funds will be available to support travel where appropriate.
How to Apply: Please send a CV and cover letter stating your qualifications, relevant
experience, wider experience, and why you think you are a good candidate for
the PhD position by post.
experience, wider experience, and why you think you are a good candidate for
the PhD position by post.
Scholarship Application Deadline: The application deadline is May 31st 2013.